Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors, enhancers |
Mechanism MAO-B inhibitors(Monoamine oxidase B inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder, Major | Clinical | Canada | 15 Apr 2021 | |
Depressive Disorder, Treatment-Resistant | Clinical | Canada | 15 Apr 2021 |